HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Isthmus Partners LLC

Isthmus Partners LLC raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 36,701 shares of the company's stock after acquiring an additional 850 shares during the period. HCA Healthcare makes up about 1.6% of Isthmus Partners LLC's portfolio, making the stock its 22nd biggest position. Isthmus Partners LLC's holdings in HCA Healthcare were worth $12,682,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the business. Farther Finance Advisors LLC lifted its holdings in shares of HCA Healthcare by 26.9% in the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock valued at $395,000 after buying an additional 242 shares during the period. Oppenheimer Asset Management Inc. grew its stake in shares of HCA Healthcare by 2.5% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock worth $1,491,000 after purchasing an additional 105 shares during the period. GAMMA Investing LLC lifted its stake in shares of HCA Healthcare by 17.6% in the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock valued at $1,704,000 after purchasing an additional 737 shares during the period. Brighton Jones LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at $1,021,000. Finally, OLD National Bancorp IN boosted its stake in shares of HCA Healthcare by 5.2% during the 1st quarter. OLD National Bancorp IN now owns 1,049 shares of the company's stock worth $362,000 after acquiring an additional 52 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insiders Place Their Bets

In related news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.30% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on HCA. Morgan Stanley set a $410.00 price target on HCA Healthcare and gave the stock an "equal weight" rating in a research report on Monday, June 9th. Royal Bank Of Canada reissued an "outperform" rating and issued a $404.00 price target (up previously from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Finally, Wells Fargo & Company raised HCA Healthcare from an "underweight" rating to an "equal weight" rating and increased their target price for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Seven equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $395.71.

HCA Healthcare Stock Down 0.7%

NYSE HCA opened at $375.76 on Friday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The firm has a market cap of $90.40 billion, a PE ratio of 16.71, a P/E/G ratio of 1.30 and a beta of 1.47. The business's fifty day simple moving average is $375.13 and its 200-day simple moving average is $341.98. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. The business had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The business's revenue was up 5.7% compared to the same quarter last year. During the same quarter last year, the firm earned $5.36 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were issued a $0.72 dividend. The ex-dividend date was Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.77%. HCA Healthcare's dividend payout ratio (DPR) is currently 12.81%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.